Conference Coverage (Retrovirus)
AIDS Vaccine Data Called "Unpleasant, Unpalatable"
Published in AIDS Weekly, February 19th, 1996
Because of this reluctance it has been difficult to learn what the data have to offer, said James Stott of England's National Institute for Biological Standards and Control, Hertfordshire, U.K.
Stott made his remarks during an invited State-of-the-Art Lecture to the 3rd Conference on Retroviruses and Opportunistic Infections, held January 28-February 1, 1996, in Washington, D.C. The conference was an independent meeting held in collaboration with the U.S. Centers for Disease Control and Prevention (CDC), the Infectious...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (1996-02-19)
More Articles from AIDS Weekly
- Conference Coverage (Retrovirus)
Radical Change in AIDS Therapy - Conference Coverage (Retrovirus)
Cell Genesys Gene Therapy Safe in Early Trial - Conference Coverage (Retrovirus)
Chemokines Can Both Suppress and Activate HIV - Conference Coverage (Retrovirus)
HIV Infected Subjects Dampen Hopes for Chiron, Genentech Vaccines - Conference Coverage (Retrovirus)
New Drug Clinically Active Against Both HIV and CMV - Conference Coverage (Retrovirus)
Tiny Region of HIV Gene Missing in Long-Term Non-Progressors - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
